标题
Targeting the Bcl-2 family for cancer therapy
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 17, Issue 1, Pages 61-75
出版商
Informa Healthcare
发表日期
2012-11-22
DOI
10.1517/14728222.2013.733001
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Downregulation of BCL2 by miRNAs augments drug-induced apoptosis - a combined computational and experimental approach
- (2012) R. Singh et al. JOURNAL OF CELL SCIENCE
- A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers
- (2012) James L. LaBelle et al. JOURNAL OF CLINICAL INVESTIGATION
- The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors
- (2012) James W. Hodge et al. SEMINARS IN ONCOLOGY
- Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis
- (2011) H. Sun et al. BLOOD
- Targeting Mcl-1 for the therapy of cancer
- (2011) Bridget A Quinn et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells
- (2011) Belal Azab et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity
- (2011) R. Dash et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Optically Pure Apogossypolone Derivative as Potent Pan-Active Inhibitor of Anti-Apoptotic Bcl-2 Family Proteins
- (2011) Jun Wei et al. Frontiers in Oncology
- Mitochondrial signaling in cell death via the Bcl-2 family
- (2010) Brian Leibowitz et al. CANCER BIOLOGY & THERAPY
- The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
- (2010) Scott Ackler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells
- (2010) Jingxuan Pan et al. CANCER LETTERS
- A Bax-Mediated Mechanism for Obatoclax-Induced Apoptosis of Cholangiocarcinoma Cells
- (2010) R. L. Smoot et al. CANCER RESEARCH
- Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma
- (2010) J. J. Hwang et al. CLINICAL CANCER RESEARCH
- Haematopoietic response and bcl-2 expression in patients with acute myeloid leukaemia
- (2010) Claudia Bincolettu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine
- (2010) Benedetto Farsaci et al. INTERNATIONAL JOURNAL OF CANCER
- The BH3 α-Helical Mimic BH3-M6 Disrupts Bcl-XL, Bcl-2, and MCL-1 Protein-Protein Interactions with Bax, Bak, Bad, or Bim and Induces Apoptosis in a Bax- and Bim-dependent Manner
- (2010) Aslamuzzaman Kazi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and Biological Evaluation of Apogossypolone Derivatives as Pan-active Inhibitors of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins
- (2010) Jun Wei et al. JOURNAL OF MEDICINAL CHEMISTRY
- BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins
- (2010) Jun Wei et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines
- (2010) S. K. Tahir et al. MOLECULAR CANCER THERAPEUTICS
- GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy
- (2010) N Heidari et al. Cell Death & Disease
- Molecular fingerprinting of radiation resistant tumors: Can we apprehend and rehabilitate the suspects?
- (2009) Charles J Rosser et al. BMC CANCER
- Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
- (2009) W. A. Michaud et al. CLINICAL CANCER RESEARCH
- Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands
- (2009) Erinna F. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
- (2009) Susan O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway
- (2009) Zhe-Yu Hu et al. Journal of Translational Medicine
- Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins
- (2009) J. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma
- (2008) L. Paoluzzi et al. BLOOD
- A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a Killer
- (2008) Siva Kumar Kolluri et al. CANCER CELL
- Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax)
- (2008) M. Konopleva et al. CANCER RESEARCH
- Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
- (2008) C. L. Hann et al. CANCER RESEARCH
- Retracted: TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer
- (2008) Zhiwei Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins
- (2008) Cheol-Min Park et al. JOURNAL OF MEDICINAL CHEMISTRY
- sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell
- (2007) Defeng Tian et al. CANCER LETTERS
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started